Drug Shortage Report for IZBA
Report ID | 158479 |
Drug Identification Number | 02457997 |
Brand name | IZBA |
Common or Proper name | IZBA 0.003% SOLN. 5ML |
Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | TRAVOPROST |
Strength(s) | 0.003% |
Dosage form(s) | SOLUTION |
Route of administration | OPHTHALMIC OPHTHALMIC |
Packaging size | 5ML |
ATC code | S01EE |
ATC description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2022-04-11 |
Actual start date | 2022-04-11 |
Estimated end date | 2022-05-09 |
Actual end date | 2022-05-10 |
Shortage status | Resolved |
Updated date | 2022-05-11 |
Company comments | Delay related to packaging component |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2022-04-11 | English | Compare |
v2 | 2022-04-11 | French | Compare |
v3 | 2022-04-11 | English | Compare |
v4 | 2022-04-11 | French | Compare |
v5 | 2022-04-12 | English | Compare |
v6 | 2022-05-06 | English | Compare |
v7 | 2022-05-06 | French | Compare |
v8 | 2022-05-10 | English | Compare |
v9 | 2022-05-10 | French | Compare |
v10 | 2022-05-11 | English | Compare |
Showing 1 to 10 of 10